ctrl K

Watchlist Price Alert

Adamas Pharmaceuticals In... (ADMS)

NASDAQ: ADMS · Real-Time Price · USD

8.22

0.00 (0.00%)

At close: Apr 24, 2025, 3:47 PM

Adamas Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	71.66M	65.77M	56.6M	91.32M	23.73M
Short-Term Investments	11.71M	66.83M	154.26M	82.13M	89.92M
Long-Term Investments	n/a	n/a	n/a	2.99M	22.29M
Other Long-Term Assets	38K	1.34M	2.79M	878K	38K
Receivables	9.29M	7.03M	6.35M	1.37M	962K
Inventory	7.29M	5.27M	5.12M	1.7M	n/a
Other Current Assets	11.78M	5.42M	6.03M	2.65M	2.37M
Total Current Assets	111.74M	150.32M	228.37M	179.18M	116.99M
Property-Plant & Equipment	8.26M	10.5M	3.65M	3.13M	3.16M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	8.29M	11.84M	6.44M	7M	25.49M
Total Assets	120.03M	162.16M	234.81M	186.18M	142.47M
Account Payables	2.14M	6.93M	6.57M	3.88M	3.59M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	3.66M	2.04M	1.66M	n/a	n/a
Other Current Liabilities	29.07M	17.98M	16.04M	12.73M	6.15M
Total Current Liabilities	34.87M	26.95M	24.28M	16.61M	9.74M
Long-Term Debt	126.31M	125.67M	117.46M	102.65M	n/a
Other Long-Term Liabilities	8.83M	10.43M	3.2M	796K	547K
Total Long-Term Liabilities	135.14M	136.1M	120.65M	103.44M	547K
Total Liabilities	170M	163.05M	144.93M	120.05M	10.29M
Total Debt	129.96M	127.72M	119.12M	102.65M	n/a
Common Stock	34K	33K	32K	28K	27K
Retained Earnings	-505.29M	-447.88M	-342.7M	-211.7M	-122.21M
Comprehensive Income	n/a	16K	-264K	-167K	-193K
Shareholders Equity	-49.98M	-893K	89.89M	66.13M	132.18M
Total Investments	11.71M	66.83M	154.26M	85.12M	112.21M